FOXP3 and breast cancer: Some other studies, however, did not find any significant predictive role for Tregs in BC [11,148] or intriguingly reported that Foxp3 expression in tumor tissue is an independent predictor of better outcomes in HER2+ patients [201] or those who received chemotherapy [202].